Pulished Date August, 2019
ID: 3178
Share on
Share on

Asia Pacific Blood Screening Market Research Report - By Technology, Product & End User , By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2019-2024)

Pulished: August, 2019
ID: 3178
Pages: 150

Asia Pacific Blood Screening Market Size & Growth (2019 – 2024):

The Size of Asia Pacific Blood Screening Market is valued at USD 0.29 billion in 2019 and is evaluated to reach USD 0.44 billion by the year 2024, growing at a CAGR of 7.9% during the forecast period 2019-2024.

The market is exhibiting obvious potential in the specified gauging period. The Asia Pacific is expected to be the quickest developing region because of the expanding speculation of industry players, government activities, and raising awareness about the transmission of diseases during its transfusion.

In 2018, reagent commanded the item section. Presentation of new measures for the discovery of different illnesses is relied upon to empower the fragment to pick up the greatest offer of market in the coming years. For example, in January 2015 the FDA affirmed Roche's blood screening measure COBAS TaqScreen MPX Test for the discovery and distinguishing proof of HCV, HIV, and HBV.

The colossal number of progressing improvements and advancements in the social insurance and hardware division, rising spending abilities and the usability of restorative devices, the rising rates of chronic infections among all demographics, every one of these variables has prompted the expanded reception of the innovation thus expanding the development. Variables like high throughput test examination and expanded work process productivity contribute toward the development of this market.

This examination covers the blood tests that are utilized routinely to screen, observing and assessing by utilizing analyzers (counting computerized analyzers) and coordinated frameworks. This report additionally covers home-checking devices and test strips and the associated calibration reagents. The report breaks down and evaluates restorative and screening uses of blood tests for human conditions, for example, diabetes, coronary illness, immune system disorders, tumor, blood disorders, hormonal irregular characteristics, contamination, and pregnancy.

Asia Pacific Blood Screening Market has been segmented and sub-segmented into the following categories

  • By Technology: Nucleic Acid Amplification, Elisa, Rapid Test, NGS, Western Blotting.
  • By Product: Instrument, Reagent & Kits, and Software.
  • By End User: Blood bank, Hospital.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

Top Companies leading the Asia Pacific Blood Screening Market Profiled in the Report are Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Ortho Clinical Diagnostics, Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, Grifols, Siemens AG, Beckman Coulter, Inc.

1.Introduction          

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions  

2. Research Methodology    

                2.1 Introduction       

                2.2 Research Phases        

  2.2.1 Secondary Research                           

  2.2.2 Primary Research                 

  2.2.3 Econometric Modelling                      

  2.2.4 Expert Validation                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview

                3.1 Executive Summary  

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints      

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation       

                5.1 Technology   

  5.1.1 Nucliec Acid Amplification Test                       

        6.3.1 Transcription-Mediated Amplification (TMA)           

        6.3.2 Real-Time Polymerase Chain Reaction (PCR             

  5.1.2 rCPR                           

  5.1.3 ELISA                         

        5.1.3.1 ELISA Market, By Platform            

      5.1.3.1.1 Chemiluminescence Immunoassay (CLIA)

      5.1.3.1.2 Fluorescence Immunoassay (FIA)

     5.1.3.1.3 Colorimetric Immunoassay (CI)

        5.1.3.2 ELISA Market, By Generation      

     5.1.3.2.1 First-Generation ELISA

     5.1.3.2.2 Second-Generation ELISA

     5.1.3.2.3 Third-Generation ELISA

     5.1.3.2.4 Fourth-Generation & Above

  5.1.4 CLIA                           

  5.1.5 Flourescence Assay                             

  5.1.6 Rapid Test 

  5.1.7 NGS                           

  5.1.8 Western Blotting                  

  5.1.9  Y-o-Y Growth Analysis, By Technology                       

  5.1.10  Market Attractiveness Analysis, By Technology                   

  5.1.11  Market Share Analysis, By Technology                    

                5.2 Product

  5.2.1 Instrument                             

        5.2.1.1 Rental Purchase

        5.2.1.2 Outright Purchase            

  5.2.2 Reagent and Kits                  

        5.2.2.1 NAT Reagents & Kits       

     5.2.2.1.1 Enzymes and Polymerases

     5.2.2.1.2 Standards and Controls

     5.2.2.1.3 Probes and Primers

     5.2.2.1.4 Buffers, Nucleotides and Solutions

     5.2.2.1.5 Labeling and Detection Reagents

        5.2.2.2 ELISA Reagents & Kits     

     5.2.2.2.1 Immunosorbents

      5.2.2.2.2 Controls

     5.2.2.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)

     5.2.2.2.4 Substrates (Of Enzymes)

     5.2.2.2.5 Sample Diluents and Wash Solutions

  5.2.3 Software                  

  5.2.4 Y-o-Y Growth Analysis, By Product 

  5.2.5 Market Attractiveness Analysis, By Product                             

  5.2.6 Market Share Analysis, By Product 

                5.3 End User        

  5.3.1 Blood Bank

  5.3.2 Hospital                    

  5.3.3 Y-o-Y Growth Analysis, By End User                             

  5.3.4  Market Attractiveness Analysis, By End User                          

  5.3.5  Market Share Analysis, By End User                            

  5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis       

                6.1 Introduction       

  6.1.1 Regional Trends                    

  6.1.2 Impact Analysis                     

  6.1.3 Y-o-Y Growth Analysis                        

        6.1.3.1 By Geographical Area     

        6.1.3.2 By Technology   

        6.1.3.3 By Product           

        6.1.3.4 By End User        

  6.1.4  Market Attractiveness Analysis                     

        6.1.4.1 By Geographical Area     

        6.1.4.2 By Technology   

        6.1.4.3 By Product           

        6.1.4.4 By End User        

  6.1.5  Market Share Analysis                      

        6.1.5.1 By Geographical Area     

        6.1.5.2 By Technology   

        6.1.5.3 By Product           

        6.1.5.4 By End User        

                6.2 China     

                6.3 India      

                6.4 Japan    

                6.5 South Korea       

                6.6 Australia        

7.Strategic Analysis 

                7.1 PESTLE analysis 

  7.1.1 Political                     

  7.1.2 Economic                 

  7.1.3 Social                         

  7.1.4 Technological                         

  7.1.5 Legal                          

  7.1.6 Environmental                       

                7.2 Porter’s Five analysis      

  7.2.1 Bargaining Power of Suppliers                        

  7.2.2 Bargaining Power of Consumers                    

  7.2.3 Threat of New Entrants                     

  7.2.4 Threat of Substitute Products and Services

  7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis  

                8.1 Grifols   

  8.1.1 Overview                 

  8.1.2 Product Analysis                   

  8.1.3 Financial analysis                  

  8.1.4 Recent Developments                       

  8.1.5 SWOT analysis                       

  8.1.6 Analyst View                          

                8.2 Thermo Fisher Scientific

                8.3 Roche Diagnostics      

                8.4 BioMerieux  

                8.5 Bio-Rad Laboratories      

                8.6 Siemens Heathineers     

                8.7 Abbott Laboratories       

                8.8 Ortho Clinical diagnostics        

                8.9 Becton  

                8.10 Dickinson and Company       

                8.11 Beckman Coulter     

9.Competitive Landscape     

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis         

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities   

Appendix    

                a) List of Tables  

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • to provide both individuals and organizations a strong financial foothold in the marketInvestment opportunitiesExpertly devised analyst overview along with
  •  
  1. Asia-Pacific Blood Screening Market By Technology, From 2019-2024 ( USD Billion )
  2. Asia-Pacific Nucliec Acid Amplification Market By Region, From 2019-2024 ( USD Billion )
  3. Asia-Pacific rCPR Market By Region, From 2019-2024 ( USD Billion )
  4. Asia-Pacific ELISA Market By Region, From 2019-2024 ( USD Billion )
  5. Asia-Pacific CLIA Market By Region, From 2019-2024 ( USD Billion )
  6. Asia-Pacific Flourescence Assay Market By Region, From 2019-2024 ( USD Billion )
  7. Asia-Pacific Rapid Test Market By Region, From 2019-2024 ( USD Billion )
  8. Asia-Pacific NGS Market By Region, From 2019-2024 ( USD Billion )
  9. Asia-Pacific Western Blotting Market By Region, From 2019-2024 ( USD Billion )
  10. Asia-Pacific Blood Screening Market By Product, From 2019-2024 ( USD Billion )
  11. Asia-Pacific Instrument Market By Region, From 2019-2024 ( USD Billion )
  12. Asia-Pacific Reagent and Kits Market By Region, From 2019-2024 ( USD Billion )
  13. Asia-Pacific Software Market By Region, From 2019-2024 ( USD Billion )
  14. Asia-Pacific Blood Screening Market By End User, From 2019-2024 ( USD Billion )
  15. Asia-Pacific Blood Bank Market By Region, From 2019-2024 ( USD Billion )
  16. Asia-Pacific Hospital Market By Region, From 2019-2024 ( USD Billion )
  17. Japan Blood Screening Market By Technology, From 2019-2024 ( USD Billion )
  18. Japan Blood Screening Market By Product, From 2019-2024 ( USD Billion )
  19. Japan Blood Screening Market By End User, From 2019-2024 ( USD Billion )
  20. China Blood Screening Market By Technology, From 2019-2024 ( USD Billion )
  21. China Blood Screening Market By Product, From 2019-2024 ( USD Billion )
  22. China Blood Screening Market By End User, From 2019-2024 ( USD Billion )
  23. India Blood Screening Market By Technology, From 2019-2024 ( USD Billion )
  24. India Blood Screening Market By Product, From 2019-2024 ( USD Billion )
  25. India Blood Screening Market By End User, From 2019-2024 ( USD Billion )
  26. Australia Blood Screening Market By Technology, From 2019-2024 ( USD Billion )
  27. Australia Blood Screening Market By Product, From 2019-2024 ( USD Billion )
  28. Australia Blood Screening Market By End User, From 2019-2024 ( USD Billion )
  29. South Korea Blood Screening Market By Technology, From 2019-2024 ( USD Billion )
  30. South Korea Blood Screening Market By Product, From 2019-2024 ( USD Billion )
  31. South Korea Blood Screening Market By End User, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample